Biocompare
Biocompare is a B2B product comparison and buyer education platform for life scientists, offering searchable databases, peer reviews, and editorial content across antibodies, reagents, and lab equipment, monetized through advertising, featured placements, lead generation, and market intelligence products sold to life science suppliers.
- Company typePrivate
- Founded1999
- HeadquartersSan Francisco, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
What Biocompare does
Biocompare is a B2B product comparison and buyer education platform for the life sciences industry, operated as a division of privately held CompareNetworks, Inc. The platform enables researchers at academic, pharmaceutical, biotech, and government labs to search, compare, and review millions of life science products, including antibodies, ELISA kits, biomolecules, flow cytometry instruments, microscopes, PCR reagents, and lab equipment, sourced from hundreds of suppliers. Core technical components include the Antibody Search Tool with multi-attribute filtering, a comprehensive product comparison database, a user-generated Product Review platform, the Flow Panel Builder, and editorial content modules (articles, bench tips, ebooks, webinars, Future Lab content hubs) spanning techniques such as Western blot, CRISPR, NGS, and cell and gene therapy. Biocompare acquired Scilan in 2022 to add AI/ML capabilities for content analysis and market intelligence.
Biocompare operates a two-sided model in which the platform is free for researchers and revenue is generated entirely from the supplier side through advertising, featured product placements, sponsored content, lead generation via quote requests, and structured market intelligence products such as the 2025 Antibody Market Report. Go-to-market is sales-led on the supplier side and content/SEO-driven on the researcher side, with topic-specific eNewsletters, social media presence, and industry event coverage as primary demand and engagement channels. The company has executed three acquisitions since 2021 (Chromocyte, Scilan, SEQanswers) to expand into flow cytometry, AI/ML, and NGS communities, and maintains GDPR and CCPA compliance under its parent CompareNetworks, Inc.
Biocompare firmographics
Firmographics- Name
- Biocompare
- Legal name
- CompareNetworks, Inc.
- Website
- https://biocompare.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Biocompare is a B2B product comparison and buyer education platform for life scientists, offering searchable databases, peer reviews, and editorial content across antibodies, reagents, and lab equipment, monetized through advertising, featured placements, lead generation, and market intelligence products sold to life science suppliers.
- Ownership category
- akta.pro rank
Where Biocompare is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Biocompare business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Advertising and Lead Generation: Biocompare generates revenue by allowing life science suppliers to advertise products and generate qualified leads from researchers using the platform. The platform connects suppliers with buyers through quote requests and product inquiries.
- Featured Product Placements: Suppliers can pay for premium product placements, featured listings, and promotional placements within the platform's product categories and search results.
- Content Marketing Services: Sponsored content, white papers, and editorial placements that provide market intelligence to researchers while promoting supplier products.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Biocompare product offering
Product offeringCore offering
Biocompare is an online buyer's guide and product comparison platform for life scientists, providing searchable access to millions of life science products from hundreds of third-party suppliers along with peer reviews, technical articles, antibody search tools, webinars, and eNewsletters. The platform is free for researchers and monetizes through advertising, sponsored content, and lead-generation services sold to life science suppliers.
Product overview
Biocompare is a life science product comparison and buyer education platform operated by CompareNetworks. The core offering consists of the Biocompare Antibody Search Tool and Product Comparison Database, which together enable researchers to search, compare, and review millions of life science products across categories including antibodies, ELISA kits, biomolecules, lab equipment, and molecular biology tools. The platform integrates content modules including Editorial Articles, Bench Tips, eBooks, Future Lab Content Hubs, Webinars/Videos, and Life Science News to support researcher education. A proprietary Product Reviews system allows users to submit and read peer evaluations of products. The eNewsletters service provides topic-specific email updates based on user interests. In April 2022, Biocompare acquired Scilan, an AI/ML solutions provider, to enhance data analysis and market intelligence capabilities for the life sciences sector.
Differentiator
Problem solved
Functional benefit
Products and services
- Antibody Search Tool
- Product Comparison Database
- Product Reviews
- Future Lab Content Hubs
- eNewsletters
- Scilan AI/ML Platform
Quantifiable outcome
- Comprehensive antibody database with millions of reagents from hundreds of suppliers
- +1 more outcomes
Companies that use Biocompare
Customer profileSegments3 records
Ideal customer profiles2 records
Biocompare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability5 records
Feature4 records
Biocompare partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ScilancoreBiocompare, a division of CompareNetworks, acquired Scilan on April 6, 2022. Scilan is a provider of artificial intelligence and machine learning solutions for life science tool providers. The acquisition aims to enhance data analysis and market intelligence capabilities in the life sciences sector.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Biocompare competitors and assessment
Company assessmentDirect peers
- LabX: Online marketplace for new and refurbished laboratory equipment and instruments. Comparable as a B2B advertising/lead-generation platform connecting life science buyers with suppliers of lab tools.
- BenchSci: AI-powered antibody search and selection platform serving life science researchers. Directly comparable as a digital product-discovery/advertising platform for life science reagents, with overlapping supplier-marketing monetization.
- CiteAb: Antibody data and citation-based ranking platform used by researchers to evaluate reagent performance. Closely comparable product (antibody search/ranking) and target user (life scientists), with supplier-data monetization.
- Addgene: Nonprofit plasmid and reagent repository with discovery and request features serving life science researchers. Comparable as a reagent-discovery/data platform with supplier-side marketing elements, though structured as a nonprofit repository.
- Thomas Scientific: Distributor and digital catalog of laboratory supplies and equipment. Comparable as a digital channel that intermediates between life science product suppliers and research buyers, with similar catalog/search functionality.
- SelectScience: Peer-review platform for laboratory products and equipment, closely analogous to Biocompare's product review system. Comparable as a researcher-driven review and product-selection platform with supplier marketing monetization.
Broad incumbents
- Abcam: Large antibody reagent supplier with its own search portal and product data portal. Comparable as a destination for antibody discovery with overlapping audience and competing with Biocompare for researcher attention, though primarily a reagent manufacturer rather than an aggregator.
- Cell Signaling Technology: Major antibody and reagent manufacturer with extensive educational/technical content hub. Comparable as a content-rich supplier destination competing for researcher mindshare and engagement that Biocompare also monetizes.
- The Scientist: Life science trade publication and media brand delivering editorial content and supplier advertising to researchers. Comparable audience (life scientists) and revenue model (advertising/sponsored content), but editorial-led rather than product-discovery-led.
- Fisher Scientific: Large-scale laboratory supplies distributor with a digital catalog serving researchers. Comparable as a digital intermediation channel for lab product suppliers, but operates as a major distributor rather than an advertising marketplace.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Biocompare social profiles
Digital presenceBiocompare compliance and trust
Trust signalCompliance2 records
Biocompare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biocompare leadership team
Management profileNumber of profiles
Profiles3 records
Biocompare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biocompare M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biocompare
What does Biocompare do?
Biocompare is an online buyer's guide and product comparison platform for life scientists, providing searchable access to millions of life science products from hundreds of third-party suppliers along with peer reviews, technical articles, antibody search tools, webinars, and eNewsletters. The platform is free for researchers and monetizes through advertising, sponsored content, and lead-generation services sold to life science suppliers.
Is Biocompare a public or private company?
Biocompare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biocompare founded?
Biocompare was founded in 1999. It employs 51 to 100 people.
Where is Biocompare based?
Biocompare is headquartered in San Francisco, United States, in the North America region.
How does Biocompare make money?
Three revenue lines are on record. Advertising and Lead Generation is the primary driver. The others are featured Product Placements and content Marketing Services.
Who are Biocompare's main competitors?
Direct peers on record are LabX, BenchSci, CiteAb, Addgene, Thomas Scientific and SelectScience. Broad incumbents are Abcam, Cell Signaling Technology, The Scientist and Fisher Scientific.
Does Biocompare have an API?
No public API is recorded for Biocompare.